Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Testosteron (ATC: G03BA03 - in der Darreichungsform Gel)
Description
The subject of this publication is the conclusion of non-exclusive rebate agreements in accordance with § 130a para. 8 SGB V for finished medicinal products with the active substance Testosterone (ATC: G03BA03 - in the dosage form of gel) within the framework of a so-called "open-house model". Under the condition of uniform contractual terms and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or joining of a rebate agreement in accordance with § 130a para. 8 SGB V for the aforementioned active substances or medicinal products. Interested pharmaceutical companies can request the participation documents and the respective contract from the contact address given. A prerequisite for the conclusion of a contract is that the interested pharmaceutical company has fully completed and signed the requested participation documents.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Renal support devices – Akutdialysegeräte - Hämofiltration, Verbrauchsmaterialien und Service
Klinikum der Ludwig-Maximilians-Universität München (LMU Klinikum)GermanyRenal support devicesRenal dialysis consumablesRepair and maintenance services of medical equipmentDeadline in 30 daysPublished on Oct 08, 2026
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tiotropiumbromid (ATC-Code: R03BB04) in der Darreichungsform Inhalationslösung.
AOK Niedersachsen. Die Gesundheitskasse.GermanyPharmaceutical productsDeadline in 718 daysPublished on Oct 08, 2026
Germany – Pharmaceutical products – 1/DLII6/VM154 - RV Arzneimittel, divers
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyPharmaceutical productsDeadline in 26 daysPublished on Oct 08, 2026
Germany – Pharmaceutical products – Open-House-Rabattverträge 2024-11
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 752 daysPublished on Oct 08, 2026